Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.

Author: FujiokaK, HompeschM, KrentzA J

Paper Details 
Original Abstract of the Article :
Pharmacotherapy directed toward reducing body weight may provide benefits for both curbing obesity and lowering the risk of obesity-associated comorbidities; however, many weight loss medications have been withdrawn from the market because of serious adverse effects. Examples include pulmonary hyper...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/dom.12657

データ提供:米国国立医学図書館(NLM)

The Shifting Sands of Obesity Treatment: Navigating the Side Effects of Pharmacotherapy

Obesity is a growing global health concern, and pharmacotherapy plays a significant role in weight management. However, the history of obesity medications is marked by challenges, with some drugs withdrawn due to serious side effects. This review chronicles the evolution of pharmacological obesity treatments, focusing on the adverse side effects associated with various medications.

A Desert of Challenges: Navigating the Side Effects of Obesity Medications

The development of effective and safe obesity medications is a challenging endeavor. This review provides a comprehensive overview of the historical evolution of obesity pharmacotherapy, highlighting the lessons learned from past experiences with medications that had serious adverse effects.

A New Dawn in the Desert: Emerging Approaches to Obesity Treatment

Despite the challenges, ongoing research and development offer hope for new and safer obesity medications. The authors highlight the importance of rigorous safety testing and post-marketing surveillance to ensure the long-term safety and efficacy of new weight-loss drugs.

Dr. Camel's Conclusion

Navigating the desert of obesity treatment requires a cautious approach. This review offers a valuable historical perspective on the challenges and successes of pharmacotherapy, emphasizing the importance of balancing potential benefits and risks.
Date :
  1. Date Completed 2017-10-31
  2. Date Revised 2017-11-28
Further Info :

Pubmed ID

26936802

DOI: Digital Object Identifier

10.1111/dom.12657

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.